Why is post-market surveillance required?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

Why is post-market surveillance required?

Post-market surveillance focuses on safety monitoring after a drug is available to the public, because the real-world use involves a much larger and more diverse population than seen in clinical trials. Rare adverse effects or longer-term safety issues may only become apparent once many people use the medicine for extended periods. This ongoing vigilance lets regulators and manufacturers detect signals, update labeling, and implement risk management measures to protect patients. That’s why the best answer highlights detecting rare adverse effects. The other options aren’t the aim of post-market surveillance: speeding up approvals happens before a product is on the market, and increasing profits or reducing manufacturing costs aren’t the purpose of safety monitoring; they don’t relate to protecting patient safety in real-world use.

Post-market surveillance focuses on safety monitoring after a drug is available to the public, because the real-world use involves a much larger and more diverse population than seen in clinical trials. Rare adverse effects or longer-term safety issues may only become apparent once many people use the medicine for extended periods. This ongoing vigilance lets regulators and manufacturers detect signals, update labeling, and implement risk management measures to protect patients.

That’s why the best answer highlights detecting rare adverse effects. The other options aren’t the aim of post-market surveillance: speeding up approvals happens before a product is on the market, and increasing profits or reducing manufacturing costs aren’t the purpose of safety monitoring; they don’t relate to protecting patient safety in real-world use.

More practice questions